2004
DOI: 10.1183/09031936.04.00014404
|View full text |Cite
|
Sign up to set email alerts
|

Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps

Abstract: Increased mucin expression is a feature of nasal polyposis. Corticosteroids reduce polyp size and symptoms, but their effect on mucin production remains unknown. In this study, the effects of intranasal corticosteroids on MUC5AC mucin expression, nasal resistance, eosinophil and neutrophil infiltration, epidermal growth factor receptor (EGFR), interleukin (IL)-8, and tumour necrosis factor (TNF)-a expression was assessed in nasal polyps.In nine subjects, one nasal polyp was removed surgically before treatment … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
34
1
1

Year Published

2004
2004
2015
2015

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(41 citation statements)
references
References 30 publications
0
34
1
1
Order By: Relevance
“…In a recent study we assessed the effects of an intranasal corticosteroid on mucus production in nasal polyps. 49 One nasal polyp was removed surgically before treatment and another was removed after 8 weeks of treatment with intranasal fluticasone (400 mg/day) in nine subjects. The polyp tissues were examined morphometrically.…”
Section: Progenitor Cells Basal Cells/ Clara Cells Stimulation (Tnf-␣)mentioning
confidence: 99%
“…In a recent study we assessed the effects of an intranasal corticosteroid on mucus production in nasal polyps. 49 One nasal polyp was removed surgically before treatment and another was removed after 8 weeks of treatment with intranasal fluticasone (400 mg/day) in nine subjects. The polyp tissues were examined morphometrically.…”
Section: Progenitor Cells Basal Cells/ Clara Cells Stimulation (Tnf-␣)mentioning
confidence: 99%
“…Immunohistochemical staining was performed on 5 mm paraffin-embedded sections. The sections were deparaffinized, rehydrated and treated with 0.3% H 2 O 2 in methyl alcohol 69 . The primary antibody (Ab) raised against sPLA2-IIA was a rabbit polyclonal Ab (4 mg ml À 1 , Cat.…”
Section: Methodsmentioning
confidence: 99%
“…5-mm paraffin sections were prepared and stained as described previously [17]. The following primary Abs were used: a polyclonal rabbit Ab raised against the N-terminus of VEGF-A (A-20, dilution 1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA); a polyclonal goat Ab raised against the phosphorylated (activated) EGFR (dilution 1:50, sc-16803; Santa Cruz Biotechnology); and a polyclonal rabbit Ab raised against the endothelial marker von Willebrand factor (vWF; Dako, Glostrup, Denmark) to identify peribronchial blood vessels.…”
Section: Immunohistochemical Staining and Morphometric Analysismentioning
confidence: 99%